Weizmann Institute, Rehovot | Israel
EMBO 1973 | MemPubC 02–04
My lab made significant contributions to the fields of vaccine development and cancer research, and to the study of parasitic diseases. I co-developed Copaxone®, a multiple sclerosis (MS) drug currently marketed worldwide. I continue to focus on the understanding of the mechanism by which Copaxone is exerting its beneficial effect. I am also developing a synthetic vaccine to provide broad range immunity against infection with influenza viruses.
Keywords: Vaccines / immunotargeting of drugs / autoimmunity / multiple sclerosis / immunoparasitology
Subject area(s): Immunology